Koninklijke DSM NV (DSMN.AS)

DSMN.AS on Amsterdam Stock Exchange

52.11EUR
11:35am EDT
Price Change (% chg)

€1.67 (+3.31%)
Prev Close
€50.44
Open
€50.49
Day's High
€52.36
Day's Low
€50.08
Volume
1,898,984
Avg. Vol
809,508
52-wk High
€52.36
52-wk Low
€36.97

DSMN.AS

Chart for DSMN.AS

About

Koninklijke DSM NV is a Netherlands-based science company, which is active in health, nutrition and materials sectors. It operates within three main business areas, namely Life Sciences, Materials Sciences and Innovation Center. The Life Sciences area comprises such segments, as Nutrition, which serves the food and beverage,... (more)

Overall

Beta: 1.13
Market Cap (Mil.): €9,151.08
Shares Outstanding (Mil.): 181.43
Dividend: 1.02
Yield (%): 2.97

Financials

  DSMN.AS Industry Sector
P/E (TTM): 33.40 20.12 18.88
EPS (TTM): 1.51 -- --
ROI: 3.10 8.59 16.90
ROE: 4.20 10.45 19.12
Search Stocks

Psychiatrists unveil their long-awaited diagnostic "bible"

NEW YORK - The long-awaited, controversial new edition of the bible of psychiatry can be characterized by many numbers: its 947 pages, its $199 price tag, its more than 300 maladies (from "dependent personality disorder" and "voyeuristic disorder" to "delayed ejaculation," "kleptomania" and "intermittent explosive disorder"), each limning the potential woes of being human.

17 May 2013

Translator's toil turns James Joyce opus into Chinese sellout

SHANGHAI, Jan 31 - During the eight years it took Dai Congrong to translate "Finnegans Wake" into Chinese, she read numerous versions of the dictionary, took voluminous notes, and fought off despair and opposition from her husband.

31 Jan 2013

Translater's toil turns James Joyce opus into Chinese sellout

SHANGHAI - During the eight years it took Dai Congrong to translate "Finnegans Wake" into Chinese, she read numerous versions of the dictionary, took voluminous notes, and fought off despair and opposition from her husband.

31 Jan 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$483.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks